Cargando…
Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
Clinical and experimental studies indicate a possible link between high serum levels of fibroblast growth factor 23 (FGF23), phosphate, and parathyroid hormone (PTH), deficiency of active vitamin D (1,25D) and klotho with the development of pathological cardiac remodeling, i.e., left ventricular hyp...
Autores principales: | Leifheit-Nestler, Maren, Richter, Beatrice, Basaran, Melis, Nespor, Julia, Vogt, Isabel, Alesutan, Ioana, Voelkl, Jakob, Lang, Florian, Heineke, Joerg, Krick, Stefanie, Haffner, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021503/ https://www.ncbi.nlm.nih.gov/pubmed/29977226 http://dx.doi.org/10.3389/fendo.2018.00333 |
Ejemplares similares
-
Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
por: Eitner, Fiona, et al.
Publicado: (2022) -
FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019) -
Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018) -
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
por: Böckmann, Ineke, et al.
Publicado: (2019) -
How FGF23 shapes multiple organs in chronic kidney disease
por: Leifheit-Nestler, Maren, et al.
Publicado: (2021)